Keefe, Bruyette & Woods Issues Pessimistic Forecast for Crescent Capital BDC (NASDAQ:CCAP) Stock Price

Crescent Capital BDC (NASDAQ:CCAP) had its target price decreased by stock analysts at Keefe, Bruyette & Woods from $17.00 to $15.50 in a research report issued on Friday,Benzinga reports. The firm presently has an “outperform” rating on the stock. Keefe, Bruyette & Woods’ target price would indicate a potential upside of 14.18% from the company’s current price.

Several other research firms have also recently issued reports on CCAP. LADENBURG THALM/SH SH raised Crescent Capital BDC to a “strong-buy” rating in a research note on Friday, August 15th. Zacks Research downgraded Crescent Capital BDC from a “hold” rating to a “strong sell” rating in a report on Wednesday, October 15th. One equities research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, Crescent Capital BDC has an average rating of “Moderate Buy” and a consensus price target of $16.38.

Crescent Capital BDC Price Performance

NASDAQ:CCAP traded down $0.02 during trading hours on Friday, hitting $13.58. The stock had a trading volume of 155,996 shares, compared to its average volume of 193,801. The business has a 50 day simple moving average of $14.55 and a two-hundred day simple moving average of $14.86. Crescent Capital BDC has a 1-year low of $13.30 and a 1-year high of $20.19. The company has a quick ratio of 1.27, a current ratio of 1.27 and a debt-to-equity ratio of 1.22.

Crescent Capital BDC (NASDAQ:CCAP) last released its quarterly earnings results on Wednesday, November 12th. The company reported $0.46 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.47 by ($0.01). The firm had revenue of $41.35 million for the quarter, compared to analysts’ expectations of $42.35 million. Crescent Capital BDC had a return on equity of 9.71% and a net margin of 20.84%. Analysts expect that Crescent Capital BDC will post 2.09 EPS for the current year.

Insider Transactions at Crescent Capital BDC

In other Crescent Capital BDC news, Director Raymond Barrios acquired 3,245 shares of Crescent Capital BDC stock in a transaction on Monday, August 25th. The shares were bought at an average price of $15.63 per share, with a total value of $50,719.35. Following the completion of the purchase, the director owned 19,177 shares in the company, valued at $299,736.51. This trade represents a 20.37% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through the SEC website. Insiders own 1.14% of the company’s stock.

Institutional Investors Weigh In On Crescent Capital BDC

Several large investors have recently modified their holdings of the business. Franklin Resources Inc. raised its position in shares of Crescent Capital BDC by 7.0% during the third quarter. Franklin Resources Inc. now owns 540,460 shares of the company’s stock worth $7,707,000 after purchasing an additional 35,534 shares during the period. Ares Management LLC raised its holdings in Crescent Capital BDC by 10.0% during the 2nd quarter. Ares Management LLC now owns 516,409 shares of the company’s stock worth $7,281,000 after buying an additional 46,836 shares during the period. North Ground Capital lifted its stake in Crescent Capital BDC by 34.4% in the third quarter. North Ground Capital now owns 418,000 shares of the company’s stock valued at $5,961,000 after buying an additional 107,000 shares in the last quarter. Condor Capital Management boosted its holdings in shares of Crescent Capital BDC by 6.2% in the third quarter. Condor Capital Management now owns 326,859 shares of the company’s stock valued at $4,661,000 after buying an additional 19,121 shares during the period. Finally, Two Sigma Investments LP increased its position in shares of Crescent Capital BDC by 199.6% during the third quarter. Two Sigma Investments LP now owns 269,649 shares of the company’s stock worth $3,845,000 after acquiring an additional 179,660 shares in the last quarter. 49.46% of the stock is currently owned by institutional investors.

Crescent Capital BDC Company Profile

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.